Biochemical, pathological and oncological relevance of Gb3Cer receptor

Medical Oncology

Volumn 28, Issue SUPPL. 1, 2011, Pages

  Crossed D Signevenica, D ^a   Cikes Culic V ^a   Vuica, A ^b   Markotic A ^a  

^a UNIVERSITY OF SPLIT   (Croatia)

^b UNIVERSITY HOSPITAL SPLIT   (Croatia)

Author keywords

Antibody based cancer immunotherapy; Endothelial apoptosis; Glycosphingolipids; Lipid rafts; Verotoxins

Indexed keywords

ALPHA2 INTERFERON; ANTINEOPLASTIC AGENT; CASPASE 8; CD19 ANTIGEN; CD40 ANTIGEN; GB3CER ANTIGEN; GLOBOTRIAOSYLCERAMIDE; GLYCOLIPID; PROTEIN MCL 1; RIBOSOME RNA; UNCLASSIFIED DRUG; VEROTOXIN; VEROTOXIN 1; VEROTOXIN B;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CELL ADHESION; CYTOTOXICITY; ERYTHROCYTE; HUMAN; LIPID RAFT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 84655174997     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9732-8     Document Type: Article

References (117)

1. SI Hakomori 2000 Cell adhesion/recognition and signal transduction through glycosphingolipid microdomain Glycoconj J 17 143 151
2. S Sonnino A Prinetti L Mauri V Chigorno G Tettamanti 2006 Dynamic and structural properties of sphingolipids as driving forces for the formation of membrane domains Chem Rev 106 2111 2125
3. J Fantini M Maresca D Hammache N Yahi O Delézay 2001 Glycosphingolipid (GSL) microdomains as attachment platforms for host pathogens and their toxins on intestinal epithelial cells: activation of signal transduction pathways and perturbations of intestinal absorption and secretion Glycoconj J 17 173 179 (Pubitemid 32055903)
4. CL Stults CC Sweeley BA Macher 1989 Glycosphingolipids: structure, biological source, and properties Method Enzymol 179 167 214 (Pubitemid 20044395)
5. RL Schnaar 1991 Glycosphingolipids in cell surface recognition Glycobiology 1 477 485
6. CA Lingwood 1996 Role of verotoxin receptors in pathogenesis Trends Microbiol 4 147 153 (Pubitemid 26135305)
7. J Konowalchuk N Dickie S Stavric JI Speirs 1978 Properties of an Escherichia coli cytotoxin Infect Immun 20 575 577 (Pubitemid 8337358)
8. K Sandvig 2001 Shiga toxins Toxicon 39 1629 1635 (Pubitemid 32786996)
9. B Boyd 1994 Lipid modulation of glycolipid receptor function Eur J Biochem 223 873 878
10. A Kiarash 1994 Glycosphingolipid receptor function is modified by fatty acid content J Biol Chem 269 11138 11146
11. CA Lingwood 1996 Aglycone modulation of glycolipid receptor function Glycoconj J 13 495 503 (Pubitemid 26271265)
12. S Arab CA Lingwood 1998 Intracellular targeting of the endoplasmic reticulum/nuclear envelope by retrograde transport may determine cell hypersensitivity to verotoxin via globotriaosyl ceramide fatty isoform traffic J Cell Physiol 177 646 660 (Pubitemid 28541589)
13. H Ling 1998 Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3 Biochemistry 37 1777 1788 (Pubitemid 28099800)
14. K Sandvig B van Deurs 2000 Entry of ricin and Shiga toxin into cells: molecular mechanisms and medical perspectives EMBO J 19 5943 5950
15. O Garred B van Deurs K Sandvig 1995 Furin-induced cleavage and activation of Shiga toxin J Biol Chem 270 10817 10821
16. Y Endo 1988 Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and Shiga toxin on eukaryotic ribosomes Eur J Biochem 171 45 50 (Pubitemid 18042873)
17. M Mangeney 1993 Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen Cancer Res 53 5314 5319 (Pubitemid 23333405)
18. J Fan M Sammalkorpi M Haataja 2010 Formation and regulation of lipid microdomains in cell membranes: theory, modeling, and speculation FEBS Lett 584 1678 1684
19. K Gaus E Chklovskaia B Fazekas de Groth W Jessup T Harder 2005 Condensation of the plasma membrane at the site of T lymphocyte activation J Cell Biol 171 121 131 (Pubitemid 41434607)
20. R Tavano 2006 CD28 interaction with filamin-A controls lipid raft accumulation at the T-cell immunological synapse Nat Cell Biol 8 1270 1276 (Pubitemid 44660592)
21. DJ Chinnapen H Chinnapen D Saslowsky WI Lencer 2007 Rafting with cholera toxin: endocytosis and trafficking from plasma membrane to ER FEMS Microbiol Lett 266 129 137 (Pubitemid 44952557)
22. A Kalisiak JG Minniti E Oosterwijk LJ Old DA Scheinberg 1991 Neutral glycosphingolipid expression in B-cell neoplasms Int J Cancer 49 837 845
23. K Sandvig 2002 Pathways followed by ricin and Shiga toxin into cells Histochem Cell Biol 117 131 141 (Pubitemid 34185619)
24. JS Bonifacino R Rojas 2006 Retrograde transport from endosomes to the trans-Golgi network Nat Rev Mol Cell Biol 7 568 579 (Pubitemid 44325348)
25. W Römer 2007 Shiga toxin induces tubular membrane invaginations for its uptake into cells Nature 450 670 675 (Pubitemid 350207679)
26. T Mori 2000 Globotriaosyl ceramide (CD77/Gb3) in the glycolipidenriched membrane domain participates in B-cell receptor-mediated apoptosis by regulating Lyn kinase activity in human B cells Exp Hematol 28 1260 1268
27. YU Katagiri 1999 Activation of Src family kinase yes induced by Shiga toxin binding to globotriaosyl ceramide (Gb3/CD77) in low density, detergent-insoluble microdomains J Biol Chem 274 35278 35282 (Pubitemid 129509587)
28. T Falguières 2001 Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent resistant membranes Mol Biol Cell 12 2453 2468 (Pubitemid 33051968)
29. O Kovbasnjuk 2001 Role of lipid rafts in Shiga toxin 1 interaction with the apical surface of Caco-2 cells J Cell Sci 114 4025 4031 (Pubitemid 33115023)
30. WI Lencer D Saslowsky 2005 Raft trafficking of AB5 subunit bacterial toxins Biochim Biophys Acta 1746 314 321 (Pubitemid 41815025)
31. P Tam C Lingwood 2007 Membrane-cytosolic translocation of verotoxin A1-subunit in target cells Microbiology 153 2700 2710 (Pubitemid 47262059)
32. W Römer 2010 Actin dynamics drive membrane reorganization and scission in clathrin-independent endocytosis Cell 140 540 553
33. B Binnington D Lingwood A Nutikka CA Lingwood 2002 Effect of globotriaosyl ceramide fatty acid a-hydroxylation on the binding by verotoxin 1 and verotoxin 2 Neurochem Res 27 807 813
34. D Newburg 1993 Susceptibility to hemolytic-uremic syndrome relates to erythrocyte glycosphingolipid patterns J Infect Dis 168 476 479 (Pubitemid 23210633)
35. CA Lingwood 1999 Verotoxin/globotriaosyl ceramide recognition: angiopathy, angiogenesis and antineoplasia Biosci Rep 19 345 354 (Pubitemid 30169335)
36. K Kiguchi 2006 Characteristic expression of globotriaosyl ceramide in human ovarian carcinomaderived cells with anticancer drug resistance Cancer Sci 97 1321 1326 (Pubitemid 44614983)
37. K Sandvig 1994 Retrograde transport from the golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP J Cell Biol 126 53 64 (Pubitemid 24214928)
38. P Tam 2008 Differential intracellular trafficking and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide-containing lipid assemblies J Cell Physiol 216 750 763
39. K Burger G Gimpl F Fahrenholz 2000 Regulation of receptor function by cholesterol Cell Mol Life Sci 57 1577 1592
40. D Chark A Nutikka N Trusevych J Kuzmina C Lingwood 2004 Differential carbohydrate epitope recognition of globotriaosyl ceramide by verotoxins and a monoclonal antibody Eur J Bioch 271 405 417 (Pubitemid 38130468)
41. DC Smith 2006 The association of Shiga-like toxin with detergent-resistant membranes is modulated by glucosylceramide and is an essential requirement in the endoplasmic reticulum for a cytotoxic effect Mol Biol Cell 17 1375 1387 (Pubitemid 43376557)
42. DEE Hoey C Currie CA Lingwood DL Gally DGE Smith 2003 Binding of verotoxin 1 to primary intestinal epithelial cells expressing Gb3 results in trafficking of toxin to lysosomal compartments Cell Microbiol 5 85 97 (Pubitemid 36395123)
43. AA Khine M Firtel CA Lingwood 1998 CD77-dependent retrograde transport of CD19 to the nuclear membrane: functional relationship between CD77 and CD19 during germinal center B-cell apoptosis J Cell Physiol 176 281 292 (Pubitemid 28319711)
44. MD Maloney CA Lingwood 1994 CD19 Has a potential CD77 (Globotriaosyl ceramide)-binding site with sequence similarity to verotoxin B-subunits: implications of molecular mimicry for B cell adhesion and enterohemorrhagic Escherichia coli pathogenesis J Exp Med 180 191 201
45. TG Obrig 1988 Direct cytotoxic action of Shiga toxin on human vascular endothelial cells Infect Immun 56 2373 2378
46. K Ohmi N Kiyokawa T Takeda J Fujimoto 1998 Human microvascular endothelial cells are strongly sensitive to Shiga toxin Biochem Biophys Res Commun 251 137 141 (Pubitemid 28498076)
47. J Holgersson PA Jovall ME Breimer 1991 Glycosphingolipids of human large intestine: detailed structural characterization with special reference to blood group compounds and bacterial receptor structures J Biochem 110 120 131
48. S Schuller G Frankel AD Phillips 2004 Interaction of Shiga toxin from Escherichia coli with human intestinal epithelial cell lines and explants: Stx2 induces epithelial damage in organ culture Cell Microbiol 6 289 301 (Pubitemid 38248012)
49. B Ramegowda JE Samuel VL Tesh 1999 Interaction of Shiga toxins with human brain microvascular endothelial cells: cytokines as sensitizing agents J Infect Dis 180 1205 1213 (Pubitemid 30070205)
50. PE Eisenhauer 2001 Tumor necrosis factor alpha increases human cerebral endothelial cell Gb3 and sensitivity to Shiga toxin Infect Immun 69 1889 1894
51. PK Stricklett AK Hughes Z Ergonul DE Kohan 2002 Molecular basis for up-regulation by inflammatory cytokines of Shiga toxin 1 cytotoxicity and globotriaosylceramide expression J Infect Dis 186 976 982
52. Z Ergonul AK Hughes DE Kohan 2003 Induction of apoptosis of human brain microvascular endothelial cells by Shiga toxin J Infect Dis 187 154 158 (Pubitemid 36034486)
53. H Uchida 1999 Shiga toxins induce apoptosis in pulmonary epithelium-derived cells J Infect Dis 180 1902 1911
54. K Takahashi N Funata F Ikuta S Sato 2008 Neuronal apoptosis and inflammatory responses in the central nervous system of a rabbit treated with Shiga toxin-2 J Neuroinflamm 5 11 23
55. MF De Rosa 2008 Inhibition of multidrug resistance by adamantylgb3, a globotriasylceramide analog J Biol Chem 283 4501 4511
56. M Bielaszewska H Karch 2005 Consequences of enterohaemorrhagic Escherichia coli infection for the vascular endothelium Thromb Haemost 94 312 318 (Pubitemid 41122485)
57. H Nakao T Takeda 2000 Escherichia coli Shiga toxin J Nat Toxins 9 299 313
58. H Karch 2001 The role of virulence factors in enterohemorrhagic Escherichia coli (EHEC)-associated hemolytic: uremic syndrome Semin Thromb Hemost 27 207 213 (Pubitemid 32550162)
59. KD Forsyth 1989 Neutrophil-mediated endothelial injury in haemolytic uraemic syndrome Lancet 2 411 414 (Pubitemid 19195959)
60. M Morigi 2001 Verotoxin-1-induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress Blood 98 1828 1835
61. JC Ching NL Jones PJ Ceponis MA Karmali PM Sherman 2002 Escherichia coli shiga-like toxins induce apoptosis and cleavage of poly (ADP-ribose) polymerase via in vitro activation of caspases Infect Immun 70 4669 4677 (Pubitemid 34790981)
62. N Kiyokawa 2001 Activation of the caspase cascade during Stx1-induced apoptosis in Burkitt's lymphoma cells J Cell Biochem 81 128 142
63. C Tétaud 2003 Two distinct Gb3/CD77 signaling pathways leading to apoptosis are triggered by anti-Gb3/CD77 mAb and verotoxin-1 J Biol Chem 278 45200 45208 (Pubitemid 37432653)
64. J Garibal É Hollville B Renouf C Tétaud J Wiels 2001 Caspase-8-mediated cleavage of Bid and protein phosphatase 2A-mediated activation of Bax is necessary for Verotoxin-1-induced apoptosis in Burkitt's lymphoma cells Cell Signal 22 467 475
65. SY Lee RP Cherla I Caliskan VL Tesh 2008 Shiga toxin 1 induces apoptosis in the human myelogenous leukemia cell line THP-1 by a caspase-8-dependent, tumor necrosis factor-independent mechanism Infect Immun 73 5115 5126 (Pubitemid 41105670)
66. RD Erwert 2003 Shiga toxin induces decreased expression of the anti-apoptotic protein Mcl-1 concomitant with the onset of endothelial apoptosis Microb Pathog 35 87 93 (Pubitemid 36952287)
67. J Fujii 2003 Rapid apoptosis induced by Shiga toxin in HeLa cells Infect Immun 71 2724 2735 (Pubitemid 36522743)
68. J Gariepy 2001 The use of Shiga-like toxin 1 in cancer therapy Crit Rev Oncol Hematol 39 99 106 (Pubitemid 32551991)
69. EC LaCasse 1999 Shiga-like toxin-1 receptor on human breast cancer, lymphoma, myeloma and absence from CD34(+) hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantation Blood 94 2901 2910
70. B Salhia JT Rutka C Lingwood A Nutikka WR Van Furth 2002 The treatment of malignant meningioma with verotoxin Neoplasia 4 304 311 (Pubitemid 34755840)
71. LJ Murray JA Habeshaw J Wiels MF Greaves 1985 Expression of Burkitt lymphoma-associated antigen (defined by the monoclonal antibody 38.13) on both normal and malignant germinal-centre B cells Int J Cancer 36 561 565 (Pubitemid 16233515)
72. C Ohyama 1990 Changes in glycolipid expression in human testicular tumor Int J Cancer 45 1040 1044 (Pubitemid 20201572)
73. D Johansson 2006 Verotoxin-1 induction of apoptosis in Gb3- expressing human glioma cell lines Cancer Biol Ther 5 1211 1217 (Pubitemid 44772240)
74. S Arab 1997 Expression of the verotoxin receptor glycolipid, globotriaosylceramide, in ovarian hyperplasias Oncol Res 9 553 563 (Pubitemid 127761181)
75. P Fredman K Hedberg T Brezicka 2003 Gangliosides as therapeutic targets for cancer BioDrugs 17 155 167 (Pubitemid 36693681)
76. O Kovbasnjuk 2005 The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer Proc Natl Acad Sci USA 102 19087 19092 (Pubitemid 43049570)
77. L Johannes D Decaudin 2005 Protein toxins: intracellular trafficking for targeted therapy Gene Ther 12 1360 1368 (Pubitemid 43090385)
78. KP Janssen 2006 In vivo tumor targeting using a novel intestinal pathogen-based delivery approach Cancer Res 66 7230 7236
79. K Ludwig 2001 Antibody response to Shiga toxins Stx2 and Stx1 in children with enteropathic hemolytic-uremic syndrome J Clin Microbiol 39 2272 2279 (Pubitemid 32531493)
80. MM Levine 1992 Antibodies to shiga holotoxin and to two synthetic peptides of the B subunit in sera of patients with Shigella dysenteriae 1 dysentery J Clin Microbiol 30 1636 1641
81. AD O'Brien 1992 Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis Curr Top Microbiol Immunol 180 65 94
82. B Vingert 2006 The Shiga toxin B-subunit targets antigen in vivo to dendritic cells and elicits anti-tumor immunity Eur J Immunol 36 1124 1135
83. N Haicheur 2000 Vt B-subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I restricted presentation of peptides derived from exogenous antigens J Immunol 165 3301 3308
84. H Wang MN Griffiths DR Burton P Ghazal 2000 Rapid antibody responses by low-dose, single-step, dendritic cell-targeted immunization Proc Natl Acad Sci USA 97 847 885
85. N Haicheur 2003 The B subunit of Shiga toxin coupled to fullsize antigenic protein elicits humoral and cell-mediated immune responses associated with a Th1-dominant polarization Int Immunol 15 1 11
86. T Falguières 2008 Human colorectal tumors and metastases express Gb3 and can be targeted by an intestinal pathogen-based delivery tool Mol Cancer Ther 7 2498 2508
87. T Viel 2008 In vivo tumor targeting by the B-subunit of shiga toxin Mol Imaging 7 239 247
88. NW Rutjes BA Binnington CR Smith MD Maloney CA Lingwood 2002 Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model Kidney Int 62 832 845 (Pubitemid 35316712)
89. A Imberty M Wimmerová EP Mitchell N Gilboa-Garber 2004 Structures of the lectins from Pseudomonas aeruginosa: insight into the molecular basis for host glycan recognition Microbes Infect 6 221 228 (Pubitemid 38293301)
90. B Blanchard 2008 Structural basis of the preferential binding for globo-series glycosphingolipids displayed by Pseudomonas aeruginosa lectin I Mol Biol 383 837 853
91. U BDistler 2009 Shiga toxin receptor Gb3Cer/CD77: tumor-association and promising therapeutic target in pancreas and colon cancer PLoS ONE 4 8 e6813
92. S Schuller R Heuschkel F Torrente JB Kaper AD Phillips 2007 Shiga toxin binding in normal and inflamed human intestinal mucosa Microbes Infect 9 35 39 (Pubitemid 46149416)
93. S Ishitoya 2004 Verotoxin induces rapid elimination of human renal tumor xenografts in SCID mice J Urol 171 1309 1313 (Pubitemid 38327601)
94. S Arab J Rutka C Lingwood 1999 Verotoxin induces apoptosis and the complete, rapid, long-term elimination of human astrocytoma xenografts in nude mice Oncol Res 11 33 39
95. HM Heath-Engel CA Lingwood 2003 Verotoxin sensitivity of ECV304 cells in vitro and in vivo in a xenograft tumour model: VT1 as a tumour neovascular marker Angiogenesis 6 129 141 (Pubitemid 38173864)
96. D Johansson 2009 Expression of verotoxin-1 receptor Gb3 in breast cancer tissue and verotoxin-1 signal transduction to apoptosis BMC Cancer 9 67 76
97. GW Bornkamm A Polack D Eick R Berger GM Lenoir 1987 Chromosome translocations and Epstein-Barr virus in Burkitt's lymphoma Onkologie 10 196 204 (Pubitemid 17132667)
98. ES Jaffe 1999 Burkitt's lymphoma: a single disease with multiple variants. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues Blood 3 1124
99. J Gordon 2000 CD40 ligand, Bcl-2, and Bcl-xL spare group I Burkitt lymphoma cells from CD77-directed killing via Verotoxin-1B chain but fail to protect against the holotoxin Cell Death Differ 7 785 794
100. A Cohen GE Hannigan BRG Williams CA Lingwood 1987 Roles of globotriosyl- and galabiosylceramide in verotoxin binding and high affinity interferon receptor J Biol Chem 262 17088 17091
101. J Wiels M Fellous T Tursz 1981 Monoclonal antibody against a Burkitt lymphoma associated antigen Proc Natl Acad Sci USA 78 6485 6489
102. R Sakthivel B Christensson B Ehlin-Henriksson G Klein 1989 Immunophenotypic characterization of follicle-center-cell-derived non-Hodgkin's lymphomas Int J Cancer 43 624 630 (Pubitemid 19110097)
103. S Taga 1997 Intracellular signalling events in CD77-mediated apoptosis of Burkitt's lymphoma cells Blood 90 2757 2767 (Pubitemid 27413486)
104. G Grafton M Goodall CD Gregory J Gordon 1997 Mechanisms of antigen receptor-dependent apoptosis in human B lymphoma cell lines probed with a panel of 27 monoclonal antibodies Cell Immunol 182 45 56 (Pubitemid 28032155)
105. JM Michael MF Lavin DJ Watters 1997 Resistance to radiation-induced apoptosis in Burkitt's lymphoma cells is associated with defective ceramide signaling Cancer Res 57 3600 3605 (Pubitemid 27355513)
106. K Furukawa 2002 Expression of the Gb3/CD77 synthase gene in megakaryoblastic leukemia cells J Biol Chem 277 11247 11254
107. X-g Zhang 1994 Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma Blood 83 3654 3663
108. AJ Szczepek 1998 A high frequency of circulating B cells share clonotypic IgH VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single cell and in situ RT-PCR Blood 92 2844 2855 (Pubitemid 28469098)
109. D Bechtel J Kurth C Unkel R Küppers 2005 Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas Blood 106 4345 4350 (Pubitemid 41775946)
110. GS Arbus 2000 Verotoxin targets lymphoma infiltrates of patients with post-transplant lymphoproliferative disease Leukemia Res 24 857 864
111. A Craxton PI Chuang G Shu JM Harlan EA Clark 2000 The CD40-inducible Bcl-2 family member A1 protects B Cells from antigen receptor-mediated apoptosis Cell Immunol 200 56 62 (Pubitemid 30170080)
112. T Li K Ramirez R Palacios 1996 Distinct patterns of Fas cell surface expression during development of T- or B-lymphocyte lineages in normal, scid, and mutant mice lacking or overexpressing p53, bcl-2, or rag-2 genes Cell Growth Differ 7 107 114 (Pubitemid 26022099)
113. P Ghia 1998 Unbalanced expression of Bcl-2 family proteins in follicular lymphoma: contribution of CD40 signaling in promoting survival Blood 91 224 251
114. MJ Holder 1993 Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bcl-2 induction Eur J Immunol 23 2368 2371 (Pubitemid 23265908)
115. C Traulle B Coiffier 2005 Evolving role of rituximab in the treatment of patients with non-Hodgkin's lymphoma Future Oncol 1 297 306
116. L Béniguel 2004 identification of germinal center B cells in blood from HIV-infected drug-naive individuals in central Africa Clin Dev Immunol 11 23 27 (Pubitemid 38488763)
117. S Ramkumar D Sakac B Binnington DR Branch CA Lingwood 2009 Induction of HIV-1 resistance: cell susceptibility to infection is an inverse function of globotriaosyl ceramide levels Glycobiology 19 76 82